Тема: ADMET-характеристики производных 5-цианопиримидина

1. Chen, H. Compound Properties and their Influence on Drug Quality / H. Chen, O. Engkvist, T. Kogej // The Practice of Medicinal Chemistry. - 2015. - Vol. 4 - P. 379-393.
2. Gleeson, M.P. Generation of a Set of Simple, Interpretable ADMET Rules of Thumb / M.P. Gleeson // J. Med. Chem. - 2008. - Vol. 51 - P. 817-834.
3. Koziolek, M. Simulating the Postprandial Stomach: Biorelevant Test Methods for the Estimation of Intragastric Drug Dissolution / M. Koziolek, G. Garbacz, M. Neumann, W. Weitschies // Mol. Pharmaceutics. - 2013. - Vol. 10 - P. 2211-2221.
4. Cascone, S. The influence of dissolution conditions on the drug ADME phenomena / S. Cascone, G. Lamberti, F. De Santis, G. Titomanlio // Eur. J. Pharm. Biopharm. - 2011 - Vol. 79 - P. 382-391.
5. Gastrointestinal behavior and ADME phenomena: II. In silico Simulation / G. Lamberti, S. Cascone, F. Marra et al. // J. DrugDeliv. Sci. Technol.
- 2016. - Vol. 35 - P. 165-171.
6. Шохин, И.Е. Применение биологической модели для оценки кишечной проницаемости in vitro- монослоя эпителиальных клеток CaCO- 2 / И.Е. Шохин, Ю.И. Кулинич, Г.В. Раменская, В.Г. Кукес // Биомедицина.
- 2012. - Т.1, № 3. - С. 91-97.
7. Lennernas, H. Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo/ H. Lennernas, K. Palm, U. Fagerholm, P. Artursson // Int. J. Pharm. - 1996. - Vol. 127 - P. 103-107.
8. Guidance for Industry. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System. U.S., Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) - December 2017.
9. Sundby, E. In vitro baselining of new pyrrolopyrimidine EGFR-TK inhibitors with Erlotinib / E. Sundby, J. Han, S.J. Kaspersen, B.H. Hoff // Eur. J. Pharm. Sci. - 2015. - Vol. 80. - P. 56-65.
10. Bergstrom, C.A.S. Computational prediction of formulation strategies for beyond-rule-of-5 compounds / C.A.S. Bergstrom, W.N. Charman, C.J.H. Porter // Adv. Drug Deliv. Rev. - 2016. - Vol. 101. - P. 6-21.
11. Bharate, S.S. Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery / S.S. Bharate, R.A. Vishwakarma // Bioorg. Med. Chem. Lett. - 2015. - Vol. 25, № 7. - P. 1561-1567.
12. Chandrasekaran, B. Computer-Aided Prediction of Pharmacokinetic (ADMET) Properties / B. Chandrasekaran, S. N. Abed, O. Al-Attraqchi, K. Kuche, R. K. Tekade - Amsterdam: Elsevier Inc., 2018 - P. 810
13. Testa, B. Predicting Drug Metabolism - An Evaluation of the Expert System METEOR / B. Testa, A.-L. Balmat, A. Long, P. Judson // Chem. Biodivers. - 2005. - Vol. 2, № 7. - P. 872-885.
14. Identification of 4,5-Dihydro-1H-pyrazolo[4,3-h]quinazoline
Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors / I. Beria, D. Ballinari, J.A. Bertrand et al. // J. Med. Chem. - 2010. - Vol. 53, № 9. - P. 3532-3551.
15. Toropov, A.A. Comprehension of drug toxicity: Software and databases / A.A. Toropov, A.P. Toropova, I. Raska Jr, D. Leszczynska, J. Leszczynski // Comput. Biol. Med. - 2014. - Vol. 45. - P. 20-25.
16. Chemical toxicity prediction for major classes of industrial chemicals: Is it possible to develop universal models covering cosmetics, drugs, and pesticides? / V.M. Alves, E.N. Muratov, A. Zakharov et al. // Food Chem. Toxicol. - 2018. - Vol. 112. - P. 526-534.
17. Research advances on selective phosphatidylinositol 3 kinase 5 (PI3K5) inhibitors / J. Sun, Y. Feng, Y. Huang et al. // Bioorg. Med. Chem. Lett. - 2020. - Vol. 30, № 19. - Art. 127457.
18. The Design and Identification of Brain Penetrant Inhibitors of Phosphoinositide 3-Kinase a / T.P. Heffron, L.Salphati, B. Alicke et al. // J. Med. Chem. - 2012. - Vol. 55, № 18. - P. 8007-8020.
19. Discovery and Optimization of Pyrimidone Indoline Amide PI3K0 Inhibitors for the Treatment of Phosphatase and Tensin Homologue (PTEN)- Deficient Cancers / V. Certal, J.-C. Carry, F. Halley et al. // J. Med. Chem. - 2014.
- Vol. 57, №3. - P. 903-920.
20. Novel antiproliferative agents bearing morpholinopyrimidine scaffold as PI3K inhibitors and apoptosis inducers; design, synthesis and molecular docking / A.A. Helwa, N.M. El-Dydamony, R.A. Radwan et al. // J. Bioorg. Chem. - 2020.
- Vol. 102. - Art. 104051.
21. Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors / K. Hoegenauer, N. Soldermann, F. Zecri et al. // ACS Med. Chem. Lett. - 2017. - Vol. 8, № 9. - P. 975-980.
22. Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties / K. Hoegenauer, N. Soldermann, C. Hebach et al. // Bioorg. Med. Chem. Lett. - 2016. - Vol. 26, № 23. - P. 5657-5662.
23. Discovery of Novel PI3-Kinase 5 Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition / B.S. Safina, S. Baker, M. Baumgardner et al. // J. Med. Chem. - 2012. - Vol. 55, № 12.
- P. 5887-5900.
24. Discovery of a Novel Series of Thienopyrimidine as Highly Potent and Selective PI3K Inhibitors / F. Han, S. Lin, P. Liu et al. // ACS Med. Chem. Lett. - 2015. - Vol. 6, № 4. - P. 434-438.
25. Discovery of phosphoinositide 3-kinases (PI3K) p1100 isoform inhibitor 4-[2-hydroxyethyl(1-naphthylmethyl)amino]-6-[(2S)-2-methylmorpholin- 4-yl]-1H-pyrimidin-2-one, an effective antithrombotic agent without associated bleeding and insulin resistance / F. Giordanetto, A. Wallberg, S. Chosal et al. // Bioorg. Med. Chem. Lett. - 2012. - Vol. 22, № 21. - P. 6671-6676.
26. Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-y Inhibitors / N. Pemberton, M. Mogemark, S. Arlbrandt et al. // J. Med. Chem. - 2018. - Vol. 61, № 12. - P. 5435-5441.
27. Ertl, P. Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties / P. Ertl, B. Rohde, P. Selzer // J. Med. Chem. - 2000. - Vol. 43. - P. 3714-3717.
28. Matthew, L. LogD Contributions of Substituents Commonly Used in Medicinal Chemistry / L. Matthew, L.J. Crawford, J.J. Crawford // ACS Med. Chem. Lett. - 2020. - Vol. 11. - P. 72-76.

Купить